In a recent study published in Nature, researchers assessed the association between farnesoid X receptor (FXR) inhibition and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Despite significant advances in the prevention and treatment of COVID-19, the efficacy of current vaccines, antivirals and monoclonal antibodies remains variable and is challenged by the continuing ...